Latest Trials
| EudraCT Number: 2004-003616-37 | Sponsor Protocol Number: M48P3 | Start Date: 2005-02-15 | ||||||
| Sponsor Name: Chiron Behring GmbH & Co KG | ||||||||
| Full Title: M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two dif... | ||||||||
| Medical condition: TBE prophylaxis | ||||||||
|
||||||||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||
| Trial protocol: DE (Completed) | ||||||||
| Trial results: View results | ||||||||